Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Bullboard Posts
Comment by GoneBrokeon Jul 06, 2019 6:53pm
163 Views
Post# 29892665

RE:NYSE Listing?

RE:NYSE Listing?Just to add to Graham B. ( arguably one of the most unbiased ,honest and incite-full posters on this message board unlike the two pumpers we have here " Folks " ) post , It is my belief that this stock has been manipulated down to this price and will go down more as we get closer to the NYSE listing.
My reasoning is that FSD Pharma will want it to take more of our shares (and our hard earned money )  to achieve the $ 4 minimum share price of the NYSE requirement ( lets not forget the fact that this exchange is in American dollars ... so factor in the exchange rate to get to $ 4 American )
So once they list on the NYSE , they will have an extremely low amount of outstanding shares ( compared to our 1.3-1.8 billion outstanding now ) ... this will enable them to re-finance at $4 per share ( dilute the outstanding share count ) in order to finance their drug trials and buildout , as Graham B. has already stated with his post.

I'm just suggesting that it's our very own BOD's that are behind the scenes to help to manipulate the share price downward before the NYSE announcement ... you must admit that if they wanted the share price up , they would release the number of crop harvests to date and the expected revenues from the harvests ; following the sales license news release ... just my opinion.
Yes something is rotten in Denmark " Folks " ( just had to reference our carneval con-artist pumper lol)
Bullboard Posts